Earnings
ANIP
32.20
-0.59%
-0.19
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
7.86M
--
--
95.79M
--
--
0.00
--
60.80M
--
5.86M
--
170.32M
41.27M
--
--
--
3.58M
188.51M
--
57.51M
290.87M
461.19M
--
11.26M
0.00
--
--
--
--
--
22.92M
--
--
--
31.14M
78.56M
172.44M
--
--
--
14.48M
186.93M
265.49M
1000.00
214.35M
-4.97M
-2.25M
--
--
195.70M
195.70M
461.19M
FY 2019-12-31
62.33M
--
--
72.13M
--
--
1.08M
--
48.16M
--
4.00M
--
187.69M
40.55M
--
--
--
3.58M
180.39M
--
44.58M
269.09M
456.79M
--
14.61M
0.00
--
--
--
--
--
20.08M
--
--
--
17.05M
61.68M
175.81M
--
--
--
6.51M
182.32M
244.00M
1000.00
200.80M
17.58M
-723.00K
--
--
212.79M
212.79M
456.79M
FY 2018-12-31
43.01M
--
--
64.84M
--
--
0.00
--
40.50M
--
4.52M
--
152.88M
38.09M
--
--
--
3.58M
201.60M
--
34.45M
277.73M
430.60M
--
8.88M
0.00
--
--
--
--
--
22.66M
--
--
--
18.29M
165.55M
67.30M
--
--
--
496.00K
67.79M
233.34M
1000.00
186.81M
11.49M
-659.00K
--
--
197.26M
197.26M
430.60M
FY 2017-12-31
31.14M
--
--
58.79M
--
--
1.16M
--
37.73M
--
2.78M
--
131.60M
20.40M
--
--
--
1.84M
229.79M
--
28.50M
280.53M
412.14M
--
3.63M
0.00
--
--
--
--
--
23.97M
--
--
--
8.27M
39.23M
198.15M
--
--
--
0.00
198.15M
237.38M
1000.00
179.02M
-4.01M
-259.00K
--
--
174.76M
174.76M
412.14M
FY 2016-12-31
27.36M
--
--
45.90M
--
--
0.00
--
26.18M
--
3.56M
--
103.01M
11.00M
--
--
--
1.84M
175.79M
--
31.23M
219.86M
322.86M
--
3.39M
0.00
--
--
--
--
--
20.41M
--
--
--
8.15M
31.95M
120.64M
--
--
--
625.00K
121.27M
153.22M
1000.00
172.56M
-2.92M
--
--
--
169.65M
169.65M
322.86M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ANIP latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze ANI Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.